Beacon Pointe Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Beacon Pointe Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-31,386	Closed	-$853K	–	1175
2023 Q1	$853K	Sell	31,386 -4,400	-12%	-$133K	0.01%	583
2022 Q4	$1.09M	Sell	35,786 -350	-1%	-$10.5K	0.02%	481
2022 Q3	$1.09M	Sell	36,136 -900	-2%	-$28.4K	0.02%	443
2022 Q2	$1.03M	Buy	37,036 +5,625	+18%	+$160K	0.02%	462
2022 Q1	$1.06M	Buy	31,411 +5,000	+19%	+$173K	0.01%	603
2021 Q4	$1.12M	Sell	26,411 -6,039	-19%	-$269K	0.03%	361
2021 Q3	$1.48M	Buy	32,450 +23,750	+273%	+$1.09M	0.04%	333
2021 Q2	$426K	Buy	+8,700	New	+$417K	0.02%	537

Other funds holding SBIO

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Beacon Pointe Advisors's SBIO Position: Q2 2023 in Review

Beacon Pointe Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2023, closing a stake of 31,386 shares — an estimated $853K sold.

Beacon Pointe Advisors first reported a position in SBIO in Q2 2021 and held it in 8 quarters. The position peaked at $1.48M in Q3 2021. 41 funds tracked by Wall St. Rank hold SBIO as of Q2 2023.

Beacon Pointe Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2023 after selling out during the quarter.
Beacon Pointe Advisors sold 31,386 ALPS Medical Breakthroughs ETF shares in Q2 2023, an estimated $853K.
Beacon Pointe Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q2 2021 and held it in 8 quarters.
Beacon Pointe Advisors's ALPS Medical Breakthroughs ETF position peaked at $1.48M in Q3 2021.
41 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2023.

Based on Beacon Pointe Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.